Here are relevant reports on : ai-gi-pathology
-
Veterinary PoC Diagnostics Market by Product (Imaging Systems, Analyzers, Reagents), Technology (Immuno & Molecular Diagnostics), Application (Pathology, Bacteriology, Gynecology), Animal (Cat, Dog, Horse, Cattle), End User & Region - Global Forecast to 2025
The global veterinary PoC diagnostics market growth is primed to transition from $1.4 billion in 2019 to $2.4 billion by 2025, showcasing a strong CAGR of 8.9%. Key drivers include the rising prevalence of zoonotic diseases in animals and the need for rapid diagnostics, though high costs of imaging equipment pose a challenge.
- Published: May 2020
- Price: $ 4950
- TOC Available:
-
Specialty PACS Market by Type (Radiology, Orthopedics, Oncology, Pathology, Endoscopy, Women's Health), Deployment Model (On premise, Cloud), Component (Software, Service), End User (Hospital, Clinic, Diagnostic Centers, Research) - Global Forecasts to 2024
The global specialty PACS market size is projected to reach USD 3.5 billion in 2024, at a CAGR of 6.0%. Some of the prominent players offering in this market includes IBM Corporation (Merge Healthcare Incorporated) (US), McKesson Corporation (US), Agfa Healthcare (Belgium), Carestream Health (a part of Onex Corporation) (Canada), Philips Healthcare (Netherlands), Sectra AB (Sweden), Siemens Healthineers (Germany), Novarad (US), INFINITT North America (US), Intelerad Medical Systems (Canada), Topcon Corporation (Japan), Sonomed Escalon (US), Canon USA, Inc. (US) (a subsidiary of Canon Inc.), Visbion (UK), and EyePACS, LLC (US).
- Published: September 2019
- Price: $ 4950
- TOC Available:
-
Anatomic Pathology Track and Trace Solutions Market by Product (Software, Hardware (Printer & Labeling Systems), Consumables), Technology (Barcode, RFID), Application (Tissue Cassette, Slide Tracking), End User (Hospital Labs) - Global Forecast to 2023
The global anatomic pathology track and trace solutions market is projected to reach USD 695.7 million by 2023 from USD 424.2 million in 2018, at a CAGR of 10.4%. The increasing volume of diagnostic tests performed in anatomic pathology laboratories, rising number of legal cases around cancer misdiagnosis, benefits of automated labeling solutions, increasing consolidation among anatomic pathology laboratories, and the growing adoption of automated systems to enhance the efficiency of laboratories are the major factors driving the growth of this market. However, the high cost associated with the implementation of track and trace solutions in anatomic pathology laboratories is expected to restrain the growth of this market during the forecast period. The key players operating in the global anatomic pathology track and trace solutions market are Thermo Fisher Scientific (US), Leica Biosystems (Germany), General Data Healthcare (US), Ventana Medical Systems (US), Agilent Technologies (US), Sunquest Information Systems (US), Zebra Technologies Corporation (US), Primera Technology (US), Cerebrum Corporation (US), AP Easy Software Solutions (US), and LigoLab (US).
- Published: October 2018
- Price: $ 4950
- TOC Available:
-
Anatomic Pathology Market by Product & Service (Instruments (Cell Processor, Microtome), Consumable, Histopathology, Cytopathology, Application (Disease Diagnosis (Cancer (Breast, Lung), End User (Hospital Laboratories), Region - Global Forecast to 2026
The global anatomic pathology market growth is primed to transition from $35.1 billion in 2021 to $49.1 billion by 2026, showcasing a strong CAGR of 7.0%. The growth of this market is majorly driven by the high incidence of cancer and other target diseases, recommendations for cancer screening, availability of reimbursement, and the growing focus on personalized medicine.
- Published: November 2021
- Price: $ 4950
- TOC Available:
-
Cancer Diagnostics Market by Product (Consumables (Antibodies, Probes), Instruments (Pathology Instruments, Imaging Instruments, Biopsy), Technology (IVD Testing), Application (Breast Cancer, Lung Cancer), End User (Hospitals) & Region - Global Forecast to 2026
The global cancer diagnostics market growth is primed to transition from $17.2 billion in 2021 to $26.6 billion by 2026, showcasing a strong CAGR of 11.5%. This growth is driven by the increasing incidence of cancer and the rise in private diagnostic centers. Opportunities are enhanced by government and healthcare provider recommendations for early cancer screening.
- Published: April 2021
- Price: $ 4950
- TOC Available:
-
Companion Animal Diagnostic Market by Product (Consumable, Instrument), Technology (Immunodiagnostic, ELISA, PCR Test, Urinalysis, Hematology), Animal Type (Dog, Cat), Application (Clinical Pathology, Virology), End User - Global Forecast to 2031
The global Companion Animal Diagnostic market, valued at USD 3.29 billion in 2025, stood at USD 3.56 billion in 2026 and is projected to advance at a resilient CAGR of 8.7% from 2026 to 2031, culminating in a forecasted valuation of USD 5.40 billion by the end of the period. Factors driving the companion animal diagnostics market include the rising demand for rapid and accurate diagnostic testing, the rising use of advanced technologies such as molecular diagnostic tests and AI-based analyzers, and also the growing focus on preventive and early diagnostic testing for companion animals.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Microscope Camera Market by Type (Color, Monochrome), Sensor (CMOS, CCD), Resolution (SD, HD, UHD), Application (Live Cell Imaging, Pathology, Pharmaceutical & Biopharmaceutical Research), End User (Hospitals, Diagnostic Labs) - Global Forecast to 2029
The global microscope camera market, valued at US$178 million in 2023, stood at US$191 million in 2024 and is projected to advance at a resilient CAGR of 7.8% from 2024 to 2029, culminating in a forecasted valuation of US$278 million by the end of the period. Growth in this market is mainly driven by factors such as the growing prevalence of chronic diseases and advancing technological aspects in microscope cameras. Growth opportunities in the Asia Pacific region are also expected to leverage a positive environment for players playing in the microscope camera market.
- Published: September 2024
- Price: $ 4950
- TOC Available:
-
Neurodiagnostics Market by Product (Diagnostic & Imaging Systems (MRI, Ultrasound), Clinical Testing (PCR, NGS), Reagents & Consumables), Disease Pathology (Epilepsy, Stroke), End User and Region - Global Forecasts to 2024
The neurodiagnostics market is projected to reach USD 8.4 billion by 2024, at a CAGR of 7.3%. Some of the prominent players in this market includes GE Healthcare (US), Siemens Healthineers (Germany), Philips Healthcare (Netherlands), Hitachi, Ltd. (Japan), Canon, Inc. (Japan), Lifelines Neuro Company, LLC (US), Natus Medical Incorporated (US), Hoffman-La Roche AG (Switzerland), FUJIFILM Holdings Corporation (Japan), Mitsar Co., Ltd. (Russia), Advanced Brain Monitoring (US), Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories (US), QIAGEN N.V. (Netherlands), Nihon Kohden Corporation (Japan), ANT Neuro (Netherlands), Fonar Corporation (US), Fujirebio (Japan), DRG Instruments GmbH (Germany), Tecan Trading AG (Switzerland), Motion Lab Systems, Inc. (US), Rigaku Corporation (Japan), Neusoft Medical Systems Co., Ltd. (US), ELMIKO MEDICAL Sp. Z o.o. (Poland) and Ridge Diagnostics (US).
- Published: December 2019
- Price: $ 4950
- TOC Available:
-
US Microscopy Market by Product [Optical Microscope: Stereo, Digital; Electron Microscope: SEM, TEM; AFM, STM], Application (Pharma Mfg, Pathology, Drug Discovery, Toxicology), End User (Pharma-Biopharma, F&B, Academia, Semiconductor) - Forecast to 2031
The US microscopy market is projected to reach USD 3.25 billion by 2031, growing at a CAGR of 5.5% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Veterinary Reference Laboratory Market by Service (Microbiology, Immunodiagnostics, Molecular Diagnostics, PCR, ELISA, Hematology, Urinalysis), Animal (Companion, Livestock), Application (Clinical Pathology, Toxicology), Region - Global Forecast to 2030
The global veterinary reference laboratory market, valued at US$4.48 billion in 2024, stood at US$4.75 billion in 2025 and is projected to advance at a resilient CAGR of 6.3% from 2024 to 2030, culminating in a forecasted valuation of US$6.45 billion by the end of the period.
- Published: November 2025
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
